TB-500 vs CJC-1295

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

TB-500

Thymosin Beta-4 (TB-500) is a naturally occurring peptide present in almost all human and animal cells. It plays a crucial role in tissue repair and regeneration.

Full details →

CJC-1295

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce more growth hormone.

Full details →

Side-by-Side Comparison

AspectTB-500CJC-1295
MechanismTB-500 promotes cell migration and differentiation, regulates actin (a cell-building protein), and reduces inflammation. It supports the formation of new blood vessels and wound healing.CJC-1295 binds to GHRH receptors in the pituitary, triggering increased production and release of growth hormone. The DAC (Drug Affinity Complex) version extends half-life significantly.
Typical DosageResearch protocols typically use 2-2.5mg twice weekly during the loading phase, followed by maintenance dosing of 2mg every 2 weeks.CJC-1295 DAC: 1-2mg weekly. CJC-1295 no DAC (Mod GRF 1-29): 100-300mcg 2-3 times daily.
AdministrationAdministered via subcutaneous or intramuscular injection. Some protocols suggest injection near injury sites.Subcutaneous injection, often combined with a GHRP like Ipamorelin for synergistic effects. Best administered before sleep or fasted.
Side EffectsMay cause temporary fatigue, headache, or localized irritation at injection sites.Water retention, tingling in extremities, potential increase in cortisol and prolactin levels.
Best For

What They Have in Common

Both TB-500 and CJC-1295 are commonly used for:

Key Differences

Unique to TB-500:

Unique to CJC-1295:

Detailed Analysis

Both CJC-1295 and TB-500 are commonly used for Muscle Growth.

Which Should You Choose?

CJC-1295 has stronger evidence for Muscle Growth.

Ready to Learn More?